Sensitivity of Enterobacteriaceae strains to the third generation cephalosporins. 2000

A Poiată, and R Filip, and C Tuchiluş, and S Constantiniu, and I Dumistracel, and C Popa, and C Lăcătuş, and D Buiuc
Department of Microbiology, University of Medicine and Pharmacy Gr. T. Popa, Iaşi.

The aim of this study was to evaluate the in vitro activity of cefotaxime, ceftriaxone, ceftazidime, ceftibuten and aztreonam against the clinical isolates of Enterobacteriaceae. MICROORGANISMS: A total of 973 enterobacteria isolated from clinical material (urine and faeces) were tested. Strains were collected during 1996-1998 period, in some centers of Eastern Romania. SENSITIVITY STUDY: MICs were performed using the agar dilution method following standardized techniques (NCCLS, 1994). Stock solutions of antibacterial agents were prepared from their respective powder forms, in concentrations ranging from 0.03 to 128 mg/ml. Our results show a good activity of the tested antimicrobials on Escherichia coli, Shigella spp and Klebsiella spp tested, and reveal a particular behaviour for Salmonella spp, characterized by a heterogenous susceptibility. In conclusion, cefotaxime, ceftriaxone, ceftazidime, ceftibuten and aztreonam were active at low concentrations against tested isolates. Against Salmonella spp, these agents were less active: percent of resistant strains by beta-lactamase production was significant.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D004755 Enterobacteriaceae A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock. Coliform Bacilli,Enterobacteria,Ewingella,Leclercia,Paracolobactrum,Sodalis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001618 beta-Lactamases Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins. beta-Lactamase,beta Lactamase,beta Lactamases

Related Publications

A Poiată, and R Filip, and C Tuchiluş, and S Constantiniu, and I Dumistracel, and C Popa, and C Lăcătuş, and D Buiuc
January 1991, Hospital practice (Office ed.),
A Poiată, and R Filip, and C Tuchiluş, and S Constantiniu, and I Dumistracel, and C Popa, and C Lăcătuş, and D Buiuc
August 1981, Lancet (London, England),
A Poiată, and R Filip, and C Tuchiluş, and S Constantiniu, and I Dumistracel, and C Popa, and C Lăcătuş, and D Buiuc
June 2004, Emerging infectious diseases,
A Poiată, and R Filip, and C Tuchiluş, and S Constantiniu, and I Dumistracel, and C Popa, and C Lăcătuş, and D Buiuc
April 1986, Microbiologica,
A Poiată, and R Filip, and C Tuchiluş, and S Constantiniu, and I Dumistracel, and C Popa, and C Lăcătuş, and D Buiuc
December 2013, Journal of clinical microbiology,
A Poiată, and R Filip, and C Tuchiluş, and S Constantiniu, and I Dumistracel, and C Popa, and C Lăcătuş, and D Buiuc
January 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
A Poiată, and R Filip, and C Tuchiluş, and S Constantiniu, and I Dumistracel, and C Popa, and C Lăcătuş, and D Buiuc
December 1982, Antimicrobial agents and chemotherapy,
A Poiată, and R Filip, and C Tuchiluş, and S Constantiniu, and I Dumistracel, and C Popa, and C Lăcătuş, and D Buiuc
January 1986, RN,
A Poiată, and R Filip, and C Tuchiluş, and S Constantiniu, and I Dumistracel, and C Popa, and C Lăcătuş, and D Buiuc
November 1982, Bulletin of the New York Academy of Medicine,
A Poiată, and R Filip, and C Tuchiluş, and S Constantiniu, and I Dumistracel, and C Popa, and C Lăcătuş, and D Buiuc
July 1995, The Medical clinics of North America,
Copied contents to your clipboard!